SCHEMBL13659630

SCHEMBL13659630

Cc1ccc2c(Cl)c(C(=O)C(C)C)sc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.70
BCL2L1 Q07817 1/20 0.70
RAB9A P51151 9/20 0.60
NPC1 O15118 8/20 0.60
MAPT P10636 7/20 0.60
LMNA P02545 2/20 0.60
GAA P10253 1/20 0.60
SMN1; SMN2 Q16637 7/20 0.53
NPSR1 Q6W5P4 3/20 0.53
PPARG P37231 2/20 0.53
NR2E3 Q9Y5X4 1/20 0.53
NCOR2 Q9Y618 1/20 0.53
RXFP1 Q9HBX9 3/20 0.52
PKM P14618 1/20 0.51
OPRM1 P35372 2/20 0.50
BCKDK O14874 2/20 0.49
HPGD P15428 2/20 0.48
F10 P00742 1/20 0.48
POLB P06746 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13659611 0.84 BCKDK (0.68) MCL1BCL2L1RAB9ANPC1MAPT
SCHEMBL415459 0.83 MCL1 (0.77) MCL1BCL2L1RAB9ANPC1MAPT
SCHEMBL5023231 0.83 MCL1 (0.77) MCL1BCL2L1RAB9ANPC1MAPT
SCHEMBL417349 0.83 MCL1 (1.00) MCL1BCL2L1RAB9ANPC1MAPT
Hydrochloric Acid SCHEMBL11398368 0.81 MCL1 (0.97) MCL1BCL2L1RAB9ANPC1MAPT
SCHEMBL9178739 0.81 MCL1 (0.74) MCL1BCL2L1RAB9ANPC1MAPT
SCHEMBL13659633 0.81 MCL1 (0.47) MCL1BCL2L1RAB9ANPC1MAPT
SCHEMBL13659636 0.81 GPR35 (0.51) MCL1BCL2L1RAB9ANPC1MAPT
SCHEMBL13659606 0.80 MCL1 (0.65) MCL1RAB9ANPC1MAPTGAA
SCHEMBL13659632 0.79 MAPT (0.72) MCL1BCL2L1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247513-A1 BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY GENESOFT PHARMACEUTICALS, INC. (US) 2009-10-01 US disclosed
US-7329765-B2 Benzothiophene compounds having antiinfective activity GENESOFT PHARMACEUTICALS, INC. (US) 2008-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247513-A1 BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY TOP2A, TOP1, TOP2B MCL1 951/4885BCL2L1 142/4885RAB9A 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.